Skip to main content
BBOT logo

BridgeBio Oncology Therapeutics, Inc.

BBOTNASDAQHealthcareBiotechnology

$2.82Today:- (-)1Y −73.54%

As of Oct 16, 2026 close

Market cap
$236.16K
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$2.88$14.87
Volume (live)
-
Avg. volume (3M)
707.11K

BridgeBio Oncology Therapeutics, Inc. (BBOT) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for BridgeBio Oncology Therapeutics, Inc. stock.

Analyst Consensus Rating

Investment consensus from 9 professional research analysts

Consensus Rating

Buy
Based on 9 unique analysts
(10 total ratings in last 90 days)
Medium Confidence∞:1 Buy/Sell

Average Price Target

$21.00
+644.68% upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest BBOT Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Andrew Berens
Leerink Partners
BuyReiterates
$27.00 → $25.00
Priyanka Grover
JP Morgan
BuyReiterates
-
Laura Prendergast
Stifel Nicolaus
BuyMaintains
$23.00 → $15.00
John Newman
Canaccord Genuity
BuyMaintains
$23.00 → $20.00
Unknown Analyst
Wedbush
BuyMaintains
$25.00
Biren Amin
Piper Sandler
BuyMaintains
$21.00
Sean McCutcheon
Raymond James
BuyMaintains
$24.00 → $22.00
Sean Laaman
Morgan Stanley
BuyReiterates
$18.00
Unknown Analyst
Wedbush
BuyInitiates
$25.00
Mazahir Alimohamed
Oppenheimer
BuyReiterates
$22.00

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Sep 18, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for BBOT?

The analyst consensus rating for BBOT is Buy, based on the latest ratings from 9 analysts over the last 90 days.

What is the average price target for BBOT?

The average 12-month price target for BBOT is $21.00, representing an upside of 644.7% from the Oct 16, 2026 close of $2.82.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.